Transvaginal Mesh
Legal Options
In 2008, the FDA warned doctors that transvaginal placement of surgical mesh products generated more than 1,000 reports of adverse events. And late last year the The American College of Obstetricians and Gynecologists published the results of a two-year clinical study that found "no difference in overall objective and subjective cure rates" between women who received vaginal colpopexy repair with the mesh and those who received the treatment without mesh. The report also found that women who received the mesh experienced "a high vaginal mesh erosion rate".
In fact, the researchers brought the clinical trial to an early close in late 2009 because the side effects being reported were too severe to continue research. Over 15 percent of women in the study experienced erosion.
Some women have experienced painful mesh erosion, in which the skin splits and the mesh protrudes, and contraction of the mesh, leading to vaginal shrinkage.
Several manufacturers market vaginal mesh, including Ethicon/Gynecare/Johnson, Johnson and C.R.Bard, Inc and the Mentor Corporation.
The FDA issued an update to the previous notification in July of 2011. In it, the FDA reversed the previous finding of rare complications by stating that “serious complications associated with surgical mesh for transvaginal repair of POP are not rare.” This followed a review of the literature, which found increased risks associated with transvaginal mesh, no evidence of added benefits in comparison with non-mesh techniques and the newly identified complication of mesh contraction. Even with this knowledge, the FDA did not initiate a transvaginal mesh recall.
An Experienced Law Firm Can:
Request a free evalualtion now to begin the process.
Our firm works on a contingency basis which means you will not be asked to pay any money out of pocket.
This process will be very easy. Please feel free to answer all questions honestly as your information is confidential.
This process will be very easy. Please feel free to answer all questions honestly as your information is confidential.
In 2008, the FDA issued a public health notification concerning the serious complications associated with transvaginal mesh. The FDA reported over 1,000 reports in three years of complications, including: